Robberechts Anneleen, Michielsen Melissa, Steurbaut Stephane, De Meyer Guido R Y, De Loof Hans
Meduplace, Royal Pharmacists Association of Antwerp (KAVA), Antwerp, Belgium.
Laboratory of Physiopharmacology, University of Antwerp, Antwerp, Belgium.
Front Pharmacol. 2023 Oct 4;14:1258364. doi: 10.3389/fphar.2023.1258364. eCollection 2023.
Medication reviews are a structured evaluation of a patient's pharmacotherapy with the aim of optimizing medicines use and improving health outcomes. This entails detecting drug related problems and recommending interventions. A high level of quality is essential for the successful implementation of this service in community pharmacies but currently there is no instrument or tool to assess that overall quality. This study investigated the development of quality criteria of type 3 medication reviews (MR3s). After surveying the literature, an electronic questionnaire was developed to gather information about quality criteria for MR3. This survey, in Dutch, was distributed electronically. Four groups were queried: 1) pharmacists, mainly working in the Netherlands, involved in practice research and contacted through the PRISMA (Practice Research In Collaboration With Pharmacists) foundation, 2) Belgian pharmacy academics and pharmacists active in professional associations (APA), 3) Belgian pharmacists trained in medication review (MR) by the Royal Pharmacists Association of Antwerp (KAVA) and 4) Belgian pharmacy students. The survey included 57 criteria, divided into eight domains, which were ranked according to their importance by the participants. The results were analyzed statistically using the nonparametric Kruskal-Wallis test. The survey was completed by 95 participants, including 42 PRISMA pharmacists, 19 APA pharmacists, 18 KAVA pharmacists and 16 pharmacy students. Opinions from participants from the different groups overlapped significantly. The use of simple and understandable language in the conversation with the patient was considered essential by the majority. Discussing the usefulness and purpose of a MR3 with the patient was also rated highly by all groups. Differences of opinion were present in aspects about laboratory values, the use of specific tools, and reporting to and consultation with the treating physician. The participants themselves formulated a limited number of additional assessment criteria. There was widespread agreement on the hierarchy of the quality assessment criteria for MR3s. differences were related to the experience of the participants. With these results and a small number of suggested extra criteria, a quality assessment instrument for MR3 can be created.
用药评估是对患者药物治疗进行的结构化评估,目的是优化药物使用并改善健康结果。这需要发现与药物相关的问题并推荐干预措施。高质量对于在社区药房成功开展这项服务至关重要,但目前尚无评估整体质量的仪器或工具。本研究调查了3类用药评估(MR3)质量标准的制定情况。在查阅文献后,设计了一份电子问卷以收集有关MR3质量标准的信息。这份荷兰语问卷通过电子方式分发。调查了4组人员:1)主要在荷兰工作、参与实践研究并通过PRISMA(与药剂师合作进行实践研究)基金会联系的药剂师;2)比利时药学学术界人士和活跃于专业协会(APA)的药剂师;3)由安特卫普皇家药剂师协会(KAVA)培训进行用药评估(MR)的比利时药剂师;4)比利时药学专业学生。该调查包括57项标准,分为8个领域,参与者根据其重要性进行排序。使用非参数Kruskal-Wallis检验对结果进行统计分析。95名参与者完成了调查,包括42名PRISMA药剂师、19名APA药剂师、18名KAVA药剂师和16名药学专业学生。不同组参与者的意见有很大重叠。大多数人认为在与患者交谈中使用简单易懂的语言至关重要。与患者讨论MR3的有用性和目的也受到所有组的高度评价。在实验室检查值、特定工具的使用以及向主治医生报告和咨询等方面存在意见分歧。参与者自己制定了数量有限的额外评估标准。对于MR3质量评估标准的层次结构存在广泛共识。差异与参与者的经验有关。基于这些结果和少量建议的额外标准,可以创建一个MR3质量评估工具。